Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Conavi Medical Corp T.TMD

Conavi Medical Corp., formerly Titan Medical Inc., is a Canada-based company. The Company is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. The Novasight Hybrid System is intended for intravascular imaging of coronary arteries and is indicated in patients who are candidates for transluminal interventional procedures. Its Novasight Hybrid System combines both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries. Hybrid IVUS and OCT imaging provides additional information over single modality imaging in complex lesions. The versatility of hybrid imaging is useful for a variety of complex percutaneous coronary intervention (PCIs), including situations where the customer may want to image large ostial lesions with IVUS but also use OCT for diseased distal lesions and/or stent assessment.


TSX:TMD - Post by User

Comment by Bigkahuna57on Mar 06, 2021 2:01pm
425 Views
Post# 32736568

RE:RE:TMD insiders just bought shares on March 2nd

RE:RE:TMD insiders just bought shares on March 2nd This is where I see the most consolidated information about TMDI awarded options and RSU's. 

https://m.canadianinsider.com/node/7?menu_tickersearch=TMD+%7C+Titan+Medical

I don't think any of these folks purchased shares except the CFO last month.  The rest are incentive options and other valuable awards, depending on the share price in the future.  My best estimate is McNally has 1M options and can't be exactly sure, but about 800,000 RSU's? So my best estimates previously regarding a BO value, per share were $30-$40.  Which would make McNally worth $65M-$85M if he excersized and cashed all of them in.  Sounds a bit high, but I can hope. 

No one is absolutely positive about a total BO, but MDT's history is very compelling.  Their history is that they partner for a while and then buy.   Everyone's speculating as to the IP tech MDT wants from TMDI for their multi port HUGO.  So that still leave ENOS as a separate RAS device in development.  But the terms of the $1.5M loan from MDT to TMDI are so restrictive, and the collateral is so rediculous (all of the current and future IP the company owns) I can only come to the conclusion that TMDI was willing to commit 100%, if both MDT and TMDI can come to a mutual agreement for an acquisition sometime in the future.  TMDI's IP portfolia is growing pretty fast, and it's very unique.  IMO.

There's a lot more conversation taking place over on IHUB. 

Regards, BK
<< Previous
Bullboard Posts
Next >>